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Case Report
Castleman’s Disease Presenting with 
Uveal Effusion Syndrome
 Sang Hoon Park, Su Jeong Song
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
We report a rare case of multicentric Castleman’s disease that presented with ophthalmic involvement, along with a 
review of the literature. A 63-year-old male presented with decreased visual acuity in both eyes. Both eyes had se-
rous elevations of the retinas with shifting subretinal fluid and annular choroidal detachment. No retinal breaks were 
found. Laboratory tests revealed pancytopenia, hypergammaglobulinemia, and an increased erythrocyte sed-
imentation rate. Chest and abdominal computed tomographies showed multiple lymphadenopathies in the media-
stinum, abdomen, and in both inguinal areas. Histological examination of the inguinal lymph node biopsy was con-
sistent with Castleman’s disease. After combination chemotherapy, the serous elevations of both retinas and the 
annular choroidal detachments of both eyes disappeared. Ophthalmic involvement in Castleman’s disease is very 
rare, and to the authors' knowledge, this is the first report of ophthalmic involvement of Castlemans’s disease in 
Korea.
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Fig. 1. A fundus photograph of the left eye. Peripheral annular cho-
roidal detachment, shallow detachment of the retina and multiple 
retinal hemorrhages and exudates due to the underlying diabetic ret-
inopathy are shown.
Castleman’s disease is a rare, atypical lymphoproliferative 
disorder. It was first described by Benjamin Castleman in 
1956 as a ‘localized mediastinal lymph node hyperplasia re-
sembling a thymoma’ [1]. Pathologically, the disease is clas-
sified into two types, hyaline-vascular disease and plasma 
cell disease [2]. Clinically, Castleman’s disease can be divided 
into two different categories, unicentric and multicentric. 
Unicentric, or localized disease, presents with a solitary 
mass, most commonly found in the mediastinum. Multicentric, 
or systemic disease, presents with generalized lymphadenop-
athy and may involve the liver, spleen, or other organs and 
tissues [3]. However, the exact cause of this disease remains 
unknown.
Ocular involvement in Castleman’s disease is very rare, 
and we were only able to uncover four such cases in the liter-
ature [4-7]. The current report documents the first case of 
multicentric Castleman’s disease with intraocular involve-
ment in a Korean patient.
Case Report
A 63-year-old man with a 20-year history of diabetes mel-
litus was referred for surgical treatment of rhegmatogenous 
retinal detachments in both eyes. His chief complaint was the  SH Park, et al. Castleman’s Disease with Uveal Effusion Syndrome
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Fig. 2. Fluorescein angiography (FAG) of both eyes revealed numerous fluorescent blotches in the subretinal space. FAG demonstrated hypo-
fluorescence in the early phase and hyperfluorescence in the late phase resulting from leakage of fluorescein dye into the subretinal space, in 
addition to multiple microaneurysms resulting from diabetic retinopathy. (A) Early phase (right eye). (B) Late phase (right eye). (C) Early 
phase (left eye). (D) Late phase (left eye). 
deterioration of visual acuity in both eyes that had begun four 
days prior to his presentation. His visual acuity allowed only 
the visualization of hand motions at 20 cm in the right eye and 
was 20/200 in the left eye, while his intraocular pressures were 
17 mmHg and 14 mmHg in the right and left eyes, respectively. 
Slit-lamp examinations of the anterior segment and ante-
rior vitreous showed no specific findings in either eye. On di-
lated fundoscopic examination, both eyes were found to have 
serous elevations of the retina, with shifting of the subretinal 
fluid, and multiple retinal hemorrhages. Furthermore, the left 
eye had an annular choroidal detachment; however, no reti-
nal breaks were found (Fig. 1). Fluorescein angiography 
demonstrated hypofluorescence in the early phase and hyper-
fluorescence in the late phase resulting from leakage of fluo-
rescein dye into the subretinal space, in addition to multiple 
microaneurysms resulting from his preexisting diabetic ret-
inopathy (Fig. 2). Optical coherence tomography images 
through the foveas of both eyes revealed severe cystic 
changes in the foveal areas and elevations of the retinal pig-
ment epithelium (Fig. 3). Magnetic resonance imaging 
showed elevations of the eyeball contour due to the choroidal 
detachment (Fig. 4). 
Laboratory abnormalities included pancytopenia, hyper-
gammaglobulinemia, increased erythrocyte sedimentation 
rate and cerebrospinal fluid pressure (24 cmH2O), and a positive 
perinuclear antineutrophil cytoplasmatic antibody test. The 
chest and abdominal computed tomographies showed multiple 
lymphadenopathies in the mediastinum, abdomen, and in both 
inguinal areas. An inguinal lymph node biopsy was performed, 
and Castleman’s disease was diagnosed based on the histo-
pathologic findings. Combination chemotherapy was initiated 
using cyclophosphamide, doxorubicin, vincristine, and pre- 
dnisolone. Following the combination chemotherapy, the se-
rous elevation of the retina and the annular choroidal detach-
ment of both eyes disappeared. The patient’s visual acuity 
improved to 20/50 in the right eye and to 20/63 in the left eye.Korean J Ophthalmol Vol.24, No.3, 2010
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Fig. 3. Optical coherence tomography images through the foveas of both eyes revealed severe cystic changes in the foveal area and a high ele-
vation of the neurosensory retina and the retinal pigment epithelium. (A,B) Retinal map of the right eye. (C,D) Retinal map of the left eye. (E) 
Retinal thickness map of both eyes. OD=oculus dexter; OS=oculus sinister.
Discussion
Castleman’s disease is a rare disorder characterized by 
cancerous growths within lymph node tissues throughout the 
body. Commonly, the mediastinal lymph node is affected [8].
 
Castleman’s disease is divided into two main types, includ-
ing the hyaline-vascular type and the plasma cell type [2]. 
The hyaline-vascular type comprises approximately 90% of 
unicentric cases, in which patients present with a solitary 
mass, and the disease typically follows a benign course [9]. 
Most patients with unicentric Castleman’s disease can be 
treated with complete surgical ablation [10]. In contrast, the 
plasma cell type develops in a multicentric fashion, and pa-
tients suffer systemic symptoms including fever, weight loss, 
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Fig. 4. Magnetic resonance imaging. The eyeball size and scleral thickness are normal in both eyes. (A) T1-weighted image, choroidal detach-
ment shown in the left eye. (B) T2-weighted image. 
anemia, and hypergammaglobulinemia [8]. The multicentric 
form is associated with polyneuropathy, organomegaly, en-
doclinopathy, monoclonal proteinemia, skin changes, Hodgkin’s 
disease, Kaposi’s sarcoma, and acquired immunodeficiency 
syndrome [11]. Lymphoma and Kaposi’s sarcoma have been 
reported to arise in as many as 32% of patients with multi-
centric Castleman’s disease [2,9,10]. Multicentric Castleman’s 
disease with systemic manifestations is more difficult to treat 
than is the unicentric disease. Radiotherapy or steroid ther-
apy is often used as a treatment, and combination chemo-
therapy is used in patients who do not respond to steroid ther-
apy [12].
To our knowledge, ophthalmic involvement in Castleman’s 
disease is very rare. Four cases of ophthalmic involvement 
have been reported in the literature [4-7]. Three cases re-
ported orbital masses diagnosed as Castleman’s disease 
[5-7], while the final case reported a serous retinal detach-
ment along with choroidal thickening [4]. In our case, after 
combination chemotherapy for multicentric Castleman’s dis-
ease, the serous elevation of the retina and the annular cho-
roidal detachments of both eyes disappeared. Although 
Castleman’s disease is very rare and its exact mechanism of 
serous retinal detachment and choroidal detachment is un-
known, it should be considered in the differential diagnosis 
of choroidal detachment.
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